Skip to main content
. Author manuscript; available in PMC: 2008 May 5.
Published in final edited form as: Lancet. 2006 Jan 14;367(9505):144–152. doi: 10.1016/S0140-6736(06)67963-4

Table 5.

Morbidity incidence rates by treatment group


Placebo
Iron and folic acid
Iron and folic acid with zinc
Diarrhoea
Episodes 1327 1355 1286
Person-years 341.5 352.8 368.0
Rate/child per year 3.89 3.84 3.50
RR (95% CI) Ref 0.94 (0.84−1.05) 0.91 (0.81−1.01)
Median (IQR) duration (days) 2 (1−3) 2 (1−3) 2 (1−3)
Persistent diarrhoea
Episodes 24 19 27
Person-years 350.6 362.2 376.4
Rate/child per year 0.069 0.053 0.072
RR (95% CI) Ref 0.74 (0.38−1.44) 1.04 (0.56−1.91)
Median (IQR) duration (days) 18 (16−24) 17 (16−19) 18 (16−22)
Dysentery
Episodes 187 166 164
Person-years 349.6 361.4 376.0
Rate/child per year 0.53 0.46 0.44
RR (95% CI) Ref 0.78 (0.57−1.09) 0.85 (0.62−1.17)
Median (IQR) duration (days) 2 (1−3) 2 (1−3) 2 (1−3)
Acute lower respiratory infection
Episodes 481 482 461
Person-years 347.6 358.6 373.3
Rate/child per year 1.38 1.34 1.23
RR (95% CI) Ref 0.92 (0.77−1.09) 0.91 (0.76−1.08)
Median (IQR) duration (days) 3 (2−4) 3 (2−4) 3 (2−4)